Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 9:11:1659-1667.
doi: 10.2147/IDR.S173805. eCollection 2018.

Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility

Affiliations

Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility

Meng Xiao et al. Infect Drug Resist. .

Abstract

Purpose: In this study, we report results from a 5-year surveillance for noncandidal yeast species causing invasive infections from 65 hospitals in China.

Materials and methods: Species identification was carried out by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) supplemented by rDNA sequencing, and fluconazole and voriconazole susceptibilities of yeasts were determined by Clinical and Laboratory Standards Institute (CLSI) disk diffusion methods.

Results: Overall, 884 noncandidal isolates belonging to 38 species were collected. Cryptococcus neoformans was the most common (75.6%), which also comprised 96.5% of the isolates from cerebrospinal fluid (CSF) and 62.6% from blood, followed by Trichosporon asahii (6.9%) and Rhodotorula mucilaginosa (5.1%). Fluconazole susceptibility and resistant rates were 74.1% and 9.7% for C. neoformans and 81.0% and 5.2% for T. asahii. Voriconazole exhibited good activity in comparison to these two species (99.5% and 98.3% of the isolates, were susceptible). However, 100% of the R. mucilaginosa isolates were resistant to both azoles. Other noncandidal yeast species showed reduced susceptibility to fluconazole (53.3%) but most were susceptible to voriconazole (94.3%). Over the 5 years, a decrease in the proportion of fluconazole-susceptible isolates was observed for C. neoformans (90%-67%, P<0.001) and other noncandidal yeast species (91%-66%, P<0.001). Moreover, the prevalence of azole-resistant R. mucilaginosa increased from 1% to 7% (P<0.001).

Conclusion: The shift in azole susceptibilities in mainland China calls for continued surveillance for noncandidal yeasts.

Keywords: China; azole susceptibility; epidemiology; invasive fungal infections; noncandidal yeasts.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Noncandidal invasive yeast isolates collected in the five-year China Hospital Invasive Fungal Surveillance Net study. Note: Seven geographic regions in China were labeled by different colors in the map, and locations of participant hospitals were labeled by red dots.
Figure 2
Figure 2
Trends of fluconazole susceptibility over 5 years. Notes: (A) Trends of fluconazole susceptible rate. (B) Trends of fluconazole resistant rate. Abbreviation: CHIF-NET, China Hospital Invasive Fungal Surveillance Net.

Similar articles

Cited by

References

    1. Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011;11(2):142–151. - PubMed
    1. Schwartz S, Kontoyiannis DP, Harrison T, Ruhnke M. Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol. 2018;17(4):362–372. - PubMed
    1. Pande A, Non LR, Romee R, Santos CAQ. Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center. Transplant Infectious Disease. 2017;19(2):e12664. - PubMed
    1. Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med. 2015;373(15):1445–1456. - PubMed
    1. Limper AH, Adenis A, Le T, Harrison TS. Fungal infections in HIV/ AIDS. Lancet Infect Dis. 2017;17(11):e334–e343. - PubMed